US 8178109
Compositions and methods of use for MGD-CSF in disease treatment
granted A61KA61K38/00A61P
Quick answer
US patent 8178109 (Compositions and methods of use for MGD-CSF in disease treatment) held by Five Prime Therapeutics, Inc. expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/00, A61P, A61P1/04, A61P1/14